Player FM 앱으로 오프라인으로 전환하세요!
#227 Baffled by NAFLD?
Manage episode 268253135 series 1345893
Swim through the sea of acronyms as Dr Scott Matherly (@liverprof) helps us become a little less baffled by the thought of NAFLD. We discuss the initial diagnosis of fatty liver disease, indications for additional evaluation with imaging and/or biopsy, and potential treatment options. With a quarter of the world affected, it’s crucial to understand the various forms of disease and how to counsel patients about this all-too-common condition!
Show Notes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!
Credits
- Written and Produced by: Elena Gibson MD
- Infographic and Cover Art: Elena Gibson MD
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Editor: Emi Okamoto MD (written materials); Clair Morgan of nodderly.com
- Guest: Scott Matherly MD
Sponsor: Pediatrics On Call
Sponsor: VCU Health Continuing Education to offer continuing education credits for physicians and other healthcare professionals. Check out curbsiders.vcuhealth.org and create your FREE account!
Time Stamps
- 00:00 Intro
- 03:15 Guest one-liner; Picks of the Week*:
- 08:15 Sponsor
- 08:50 Case from Kashlak part 1; What is hepatic steatosis?
- 11:43 NAFLD acronyms and definitions
- 18:20 Alcohol and Fatty Liver
- 23:15 Initial Evaluation of NAFLD
- 35:12 Dr Matherly’s piel to patients with fatty
- 41:11 NASH/Fibrosis Risk Assessment
- 48:54 Outcomes in NASH with Fibrosis
- 51:20 Statins are safe in liver disease
- 56:15 Treatment Options (surgery, Vitamin E, Pioglitazone, SLGT2 inhibitors and GLP1 agonists; Coffee?!)
- 71:42 Take home points and Outro
486 에피소드
Manage episode 268253135 series 1345893
Swim through the sea of acronyms as Dr Scott Matherly (@liverprof) helps us become a little less baffled by the thought of NAFLD. We discuss the initial diagnosis of fatty liver disease, indications for additional evaluation with imaging and/or biopsy, and potential treatment options. With a quarter of the world affected, it’s crucial to understand the various forms of disease and how to counsel patients about this all-too-common condition!
Show Notes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!
Credits
- Written and Produced by: Elena Gibson MD
- Infographic and Cover Art: Elena Gibson MD
- Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Editor: Emi Okamoto MD (written materials); Clair Morgan of nodderly.com
- Guest: Scott Matherly MD
Sponsor: Pediatrics On Call
Sponsor: VCU Health Continuing Education to offer continuing education credits for physicians and other healthcare professionals. Check out curbsiders.vcuhealth.org and create your FREE account!
Time Stamps
- 00:00 Intro
- 03:15 Guest one-liner; Picks of the Week*:
- 08:15 Sponsor
- 08:50 Case from Kashlak part 1; What is hepatic steatosis?
- 11:43 NAFLD acronyms and definitions
- 18:20 Alcohol and Fatty Liver
- 23:15 Initial Evaluation of NAFLD
- 35:12 Dr Matherly’s piel to patients with fatty
- 41:11 NASH/Fibrosis Risk Assessment
- 48:54 Outcomes in NASH with Fibrosis
- 51:20 Statins are safe in liver disease
- 56:15 Treatment Options (surgery, Vitamin E, Pioglitazone, SLGT2 inhibitors and GLP1 agonists; Coffee?!)
- 71:42 Take home points and Outro
486 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.